| Title | Research Area | Implementing Organisations | Funding Organisations | Start Year | Status |
|---|---|---|---|---|---|
| Computational screening to identify plant derived DPP IV inhibitors as therapeutics of diabetes type 2 | Pharmaceutical Sciences | Motilal Nehru National Institute of Technolgy | Science and Engineering Research Board (SERB), New Delhi | 2022 | Completed |
| Exercise Imitating microRNA Lipodendriplex for the prevention and treatment of obesity | Pharmaceutical Sciences | — | — | 2022 | ongoing |
| Designing Sound-Responsive Nanodrug for Cell Therapy | Pharmaceutical Sciences | Indian Association For The Cultivation Of Science, West Bengal | Science and Engineering Research Board (SERB), New Delhi | 2022 | Completed |
| Electro-conductive and immunomodulatory macroporous hydrogel conduit for faster spinal cord regeneration | Pharmaceutical Sciences | — | — | 2022 | ongoing |
| Repurposing of drugs and validation of lead compounds against main protease and RNA dependent RNA polymerase of SARS-CoV-2 | Pharmaceutical Sciences | AMITY University, Noida, Uttar Pradesh | Department of Science and Technology (DST) | 2021 | — |
| Deciphering the redox chemistry of physical plasma-treated clinically-relevant liquids as novel therapy against ovarian cancer | Pharmaceutical Sciences | — | — | 2021 | ongoing |
| Development of computational and visualisation software for evaluating GPCR targeting drugs with the aim of mitigating coronavirus infection level | Pharmaceutical Sciences | Indian Institute of Technology (IIT), Hyderabad | Department of Science and Technology (DST) | 2020 | — |
| Development of host-directed anti-coronavirus agents | Pharmaceutical Sciences | National Research Centre for Equines (NRCE) | Department of Science and Technology (DST) | 2020 | Completed |
| Drug repurposing against key COVID-19 drug targets using advance machine learning-based algorithms | Pharmaceutical Sciences | SRM University, Haryana | Department of Science and Technology (DST) | 2020 | — |
| Discovery of structure-based antivirals against SARS-CoV-2 targeting key viral genome replication enzymes | Pharmaceutical Sciences | Indian Institute of Technology (IIT), Roorkee | Department of Science and Technology (DST) | 2020 | — |